Targeting MYCN/NCYM for cancer therapy |
| Principal Investigator / Affiliation | Yoshitaka Hippo (Department Head) / Chiba Cancer Center  Japan |
|---|---|
Tao Liu (Group Leader) / The University of New South Wales  Australia |
|
Edy Meiyanto (Professor) / Gadjah Mada University  Indonesia |
|
| Year Adopted | 2021 |
| Research Period | 3 years |
| General Description of the Research Project | The aim of this project is to develop novel therapeutic strategies for liver cancer by targeting MYCN/NCYM. The effects of anti-cancer agents inhibiting MYCN/NCYM function, obtained either from natural resources or through chemical synthesis, will be examined using patient-derived organoid and mouse models for potential translation into clinical trials. Multi-omics will reveal the molecular mechanisms underlying the tumor suppressive effects |
| Photo Gallery | |
| Reports | |
| Links |
Researchers
| Principal Investigator / Country of Research Team | 
Yoshitaka Hippo Japan
Tao Liu Australia
Edy Meiyanto Indonesia |
|---|